OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← The Facial Surgery Research Foundation - Saving Faces

2025-06-30-accounts

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

Charity registration number 1081214

SAVING FACES

ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Elliott Bernerd (Chair)
Professor Patrick Magennis (Deputy chair)
Professor Simon Holmes
Austen Smith
Atul Setia
Simon Bentley
Peter Hardee
Michael Simpson
Chief Executive Professor Iain Hutchison
Principal address 71 Tonbridge Street
King’s Cross London
WC1H 9DZ
Charity number 1081214
Independent examiner M J Bushell Audit LLP
Ground Floor, Kings House
101-135 Kings Road
Brentwood
Essex
CM14 4DR
Solicitors Field Fisher
Riverbank house
2 Swan Lane
London
EC4R 3TT
Bankers Santander Business Banking Operations
Sunderland
SR43 4FW

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

CONTENTS

Page
Trustees' report 1 - 9
Independent examiner's report 10
Statement of financial activities 11
Balance sheet 12
Notes to the financial statements 13 - 20

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

TRUSTEES’ REPORT FOR THE YEAR ENDED 30 JUNE 2025

The Trustees present their report and the financial statements of the charity for the year ended 30 June 2025.

MISSION AND ACTIVITIES

Saving Faces – The Facial Surgery Research Foundation is the only charity in the UK solely dedicated to reducing the incidence of and improving the treatment for facial injuries, disorders and diseases including oral cancer worldwide. With over 25 years of experience leading research of the highest quality, we pursue our mission of improving and saving patients’ lives by delivering world-class research projects, clinical audits, education, support and advice services in the UK and across the globe. Saving Faces applies its income as the Trustees from time to time think fit to conduct or fund research which is likely to lead to overall improvement in prevention and early detection strategies, treatment and quality of life.

Why our work is urgently needed:

Facial disease, injury and deformity are unlike any other conditions. They can harm our very being – our speaking and eating as well as our appearance. They often leave life-changing physical and emotional scars, undermining self-esteem and dignity, isolating patients from others, affecting their job opportunities and sometimes condemning them to impoverished lives in the shadows.

ACHIEVEMENT AND PERFORMANCE

RESEARCH REPORT

Prestigious Honours

Our Founder and Chief Executive, Professor Iain Hutchison has been awarded the following honours:

  1. Awarded the Life Honorary Fellowship of the British Association of Oral and Maxillofacial Surgeons (BAOMS). This is a rare award only given to distinguished individuals whose contribution in the fields of Oral and Maxillofacial and Oral Surgery are held in high esteem by the Fellows and the Council of the Association. BAOMS is a surgical specialty concerned with the diagnosis and treatment of diseases affecting the mouth, jaws, face and neck.

  2. Presented with an Honorary Fellowship of the Dental Surgery at The Royal College of Surgeons of England (RCS) in recognition of his outstanding professional contributions. This is a rare honour as there can only ever be 55 at any one time. The RCS provides world-class education, assessment and development to 30,000 surgeons, dental professionals and members of the wider surgical and dental care teams.

  3. 1 -

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

  1. Elected as an Honorary Member of the European Association for Cranio Maxillofacial Surgery (EACMFS). This rare honour reflects Professor Hutchison’s exceptional commitment to surgical excellence and patient care. EACMFS was established in 1970 by a group of innovative European surgeons who were keen to advance the specialty. It has become the most prominent and highly respected professional group for the specialty in Europe and has a high profile in other parts of the World.

  2. Presented with the British Association of Head & Neck Oncologists (BAHNO) President’s Lifetime Award 2025 for his outstanding contributions to the field of Head and Neck Cancer in the broadest sense. BAHNO is a multi-disciplinary society for healthcare professionals involved in the study and treatment of head and neck cancer.

The Nationwide Selective Elective Neck Dissection (SEND) clinical research study - unprecedented 10-year follow-up

Our groundbreaking Selective Elective Neck Dissection (SEND) clinical trial is the only nationwide research study to compare two surgical treatments for head and neck cancer, and it has revolutionised treatment globally. We assessed the effectiveness of two very different treatments for early mouth cancer, each of which was widely used. Prior to SEND, both treatments were known to be relatively successful, but for 30 years, individual surgeons in hospitals around the world had tried to determine which one was better. Unfortunately, even the most famous hospitals treated too few patients to provide the answer. We created the UK’s largest oral cancer surgical trial collaborating with 68 oral and maxillofacial surgeons treating 614 patients at 27 hospitals.

We found that removing neck glands during early mouth cancer surgery significantly reduced both death rates and tumour recurrence and because of our research, 30,000 additional lives are being saved each year worldwide - equivalent to 1 life saved every 15 minutes.

The impact of the SEND study publication has been far reaching as the USA, UK, Europe and Japan have all revised their guidelines to recommend that patients are offered the more successful treatment. Our results were published in an open-access paper in the British Journal of Cancer (BJC) and has been downloaded / read by almost 14,000 doctors and scientists with over 100 citations.

We're now embarking on an unprecedented 10-year follow-up phase of SEND, something never before accomplished. We are currently in negotiations with NHS England (formerly NHS Digital) to finalise our Data Sharing Agreement so that we capture and obtain all the relevant data fields relating to mortality and recurrence to complete this 10 year follow up. We will be signing this imminently and then we can begin data analysis. This extended monitoring will reveal critical insights into long-term survival rates, recurrence patterns, and new tumour development that could further transform treatment approaches.

Genomic Radiotherapy and Dysphagia (GRAD) Study

We received approval from the Research Ethics Committee (REC) to resume the GRAD study, following its temporary halt due to COVID-19. Phase 1 of the study has been completed at all 13 sites recruiting 1077 patients. The Phase 2 Pilot study has been completed at 3 sites using blood and saliva samples from 130 participants- this provided data for the pre-covid baseline. Bart's and the London Genome Centre have analysed these blood and saliva samples and have extracted the genetic profiles. We will now use bioinformatics to assess the association between health status and genetics, to identify which genetic factors are associated with severe complications including osteoradionecrosis and dysphagia.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

The results will provide a better understanding of the radiotherapy +/- chemotherapy and guidance on treatment decision-making for surgeons and patients. Once this analysis has been completed, the data will be published, and phase 2 will be rolled out to the remaining sites.

Saving Faces Diagnostic Advice Service - SFDADS

This electronic rapid diagnostic service is for primary care practitioners with the aim of speeding cancer referrals to the most appropriate clinician in the patient's locality and reassure those with benign disease at an early stage. The primary care clinician completes a brief pro forma and sends a photograph of lesion. They receive a response within three working days suggesting the appropriate speed of referral with the name and contact details of the appropriate secondary care clinician. It is the first of its kind in the world and in the past year has advised on 129 patients - 37 presented with suspicious lesions that were referred to the 2-week urgent cancer pathway. Since the launch of SFDADS over 1,300 referrals have been received.

Saving Faces Expert Helpline

The Saving Faces Expert Helpline is a national telephone service with a pool of over 300 previous patients with diverse oral and facial conditions who are prepared to be a “buddy” over the ‘phone to patients undergoing treatment for the same condition. This is a comprehensive patient-to-patient psychological support network.

Tissue Bank

We're in talks to donate our precious tissue bank to Queen Mary University of London and Barts and the London Hospitals. Our collection comprises of 4,810 samples from 830 donors, gathered between 2007-2017. Our tissue bank has contributed to significant research breakthroughs and we’re confident it will continue to drive innovative research.

National Head and Neck Cancer Audit (HANA)

HANA -The National Head & Neck Cancer Audit for England & Wales, tracks every new case; drives improvements in MDT performance and pathway quality. The audit has been placed on hold whilst the HANA Project Board renegotiate a contract to continue the audit with their technology partners. The Confidentiality Advisory Group has reviewed the audit and continued the audit’s Section 251 support, which allows us to collect identifiable patient data without consent.

National Jaw Surgery Patient Survey

This is an online survey to gather feedback from patients who have undergone corrective jaw surgery and it’s being completed by many sites.

The National Facial, Oral and Oculoplastic Research Centre (NFORC)

This unique research centre was a result of a formal partnership between Saving Faces and the two UK surgical societies, the British Association of Oral and Maxillofacial Surgeons (BAOMS); and the British Oculoplastic Surgical Society (BOPSS) who focus on the treatment of face and mouth diseases, injuries and disfigurement. The Royal College of Surgeons of England (RCSEng) selected NFORC as its head and neck cancer trials centre. Saving Faces provides the core funding and research staff and BAOMS and BOPSS surgeons provide the research ideas and clinical support for the trials (studies). NFORC is the world’s only trials unit dedicated to researching better treatment for facial and mouth conditions.

NFORC held meetings with consultant surgeons to discuss the progress of ongoing projects.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

NFORC Projects include:

The Wisdom Tooth Surgery Service Evaluation

Consultant Oral and Maxillofacial Surgeon Mr Geoff Chiu and Professor Paul Coulthard, President of the British Association of Oral Surgeons (BAOS), have collaborated with Saving Faces/NFORC to conduct a service evaluation to assess the standard of care and performance of dental departments and clinics.

The study team have created materials and documents to facilitate the service evaluation, including the clinical data collection forms and patient surveys. Mr Chiu and his colleagues have started to collect data to test the database and have encouraged other surgeons who perform surgical wisdom tooth treatment to undertake their own service evaluations for a 3-month period. Surgeons from 3 hospital sites have undertaken service evaluations so far. The results of the service evaluations will inform the development of a national study on surgical wisdom tooth treatment.

TMJ service survey

Consultant OMFS Mr Nadeem Saeed and OMFS registrar Dr Toby Visholm asked the Saving Faces and NFORC research team to help them to investigate current treatments for temporomandibular joint (TMJ) disorder patients with a view to improving service provision and planning. In collaboration with Mr Saeed and Dr Visholm, NFORC staff have created a survey on REDCAP to collect data on both surgical and non-surgical TMJ treatments.

Quality Outcome Measures in Oral and Maxillofacial Surgery (QOMS)

The QOMS project was set up in 2018 by the then President of BAOMS to deal with the lack of validated outcome measures in the Oral and Maxillofacial specialty against which surgical performance could be judged. QOMS is managed by BAOMS with support from Saving Faces and NFORC staff who are on the management committee. Saving Faces also provides funds for the data collection database costs and assists with patient and public involvement activities for the QOMs projects.

Publications between 1[st] July 2024 and 30[th] June 2025:

Oral and Maxillofacial Surgery Curriculum (2021) and Oral Surgery Curriculum (2023): A forensic

comparison of two documents.

Capanni PM, Magill S, Walker T, Varley I, Magennis P. Br J Oral Maxillofac Surg. 2025 Feb;63(2):125132. doi: 10.1016/j.bjoms.2024.11.003. Epub 2024 Nov 22. PMID: 39732543

Oral and maxillofacial surgery (OMFS) 'controlled' second-degree places in the UK - there are sufficient numbers (with high application ratios) to meet current and future OMFS recruitment needs in the UK.

Magennis C, Davies A, King R, Ilahi N, Morgan R, Stonier G, Howson K, Dattani A, Hamps C, Rowe A, Jenkyn I, Basyuni S, Magennis P. Br J Oral Maxillofac Surg. 2025 Feb;63(2):104-111. doi: 10.1016/j.bjoms.2024.10.236. Epub 2024 Nov 15. PMID: 39732542

Gender changes in oral and maxillofacial surgery (OMFS) in the UK 1996 to 2030. Current trends suggest gender parity of those joining the OMFS specialist list may be achieved by 2048. Magennis C, Stonier G, Rowe A, Dhariwal DK, Begley A, Magennis P. Br J Oral Maxillofac Surg. 2025 Feb;63(2):112-117. doi: 10.1016/j.bjoms.2024.10.235. Epub 2024 Nov 13. PMID: 39730241

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

Review of the 'second degree' universities of Oral and Maxillofacial Surgery (OMFS) specialists and trainees in the UK. Locations of their graduate entry medicine and graduate entry dentistry degrees, graduating between 1979-2019.

Magennis C, Magennis P. Br J Oral Maxillofac Surg. 2025 Feb;63(2):98-103. doi: 10.1016/j.bjoms.2024.07.018. Epub 2024 Nov 13. PMID: 39730240

Oral and maxillofacial surgery in the United Kingdom and Germany https://api.semanticscholar.org/CorpusID:273624280

Patrick Magennis and Hans-Peter Ulrich and Matthias Schneider and J-Ulf Wiegner.Die MKGChirurgie 2024: 17: 240 – 247

ADMINISTRATION REPORT

Fundraising

We would like to thank all our fundraisers who took on incredibly demanding challenges and every supporter who organised their own individual events to raise money for Saving Faces.

One individual bravely took on a skydive for Saving Faces and raised over £1,500.

Carols

The annual Saving Faces’ Christmas Carol concert took place on 13th December 2024 at St Bartholomew’s the Great Church with wonderful music courtesy of The Chelsea Opera Group. As always, we were amazed by the generosity of our supporters and a total of £4,450.19 was raised from the event.

Legacies and Donations in Memory

Saving Faces received legacies totalling £5,337.92 and donations in memory totalling £5,980.98.

The Alan Rickman Professorship of Facial Surgery

Our friend, the wonderful actor Alan Rickman was a generous and supportive Patron Saving of Faces, because he had known actors whose careers had been blighted by facial injury, disease or cancer. He launched Saving Faces National Facial and Oral Research Centre (NFORC) and challenged us then saying “I believe Saving Faces next project is to appoint an outstanding surgical Professor to lead NFORC . Let me help you achieve this”. When he died, he bequeathed a legacy to Saving Faces.

We are working with Alan Rickman’s friends and family to run a crowdsourcing campaign to create an endowment that permanently funds The Alan Rickman Professor of Facial Surgery.

This Professor is needed because head and neck cancer, facial injury disease and disfigurement are very common but research to improve their treatment is very poorly funded. The Alan Rickman Professor will lead research to develop new treatments and operations that will bring about better treatment and improved facial appearance and function by using the big data they collect. In addition to this, the Professor will educate, encourage and inspire future doctors and surgeons to collaborate with them in research. There will be an annual conference at which the Professor will present their research, and friends and colleagues of Alan will speak, ensuring the permanent association of his name with ground-breaking research.

Millions of people loved Alan and miss him. We are giving them an opportunity to honour him and improve thousands of people’s lives around the world at the same time.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

In October 2024, Saving Faces launched the campaign to fund the Alan Rickman Professorship of Facial Surgery and received donations from the supporters such as The Hollick Family Charitable Trust and Barbara Broccoli.

STRUCTURE, GOVERNANCE AND MANAGEMENT

The Facial Surgery Research Foundation – Saving Faces is constituted under a Trust Deed dated 28th April 2000, amended on 21 June 2000 and 12 March 2001, and is a registered charity 1081214.

Trustee Recruitment

Trustees are recruited on the recommendation of incumbent members of the Board, commensurate with the Chair’s aim to maintain a balanced composition. Applications from individuals seeking to become a Trustee will be considered as and when appropriate by the Board. The Board meet up to four times during the year.

The Board of Trustees is responsible for managing the charity and they have a wide range of skills and experience including professional and clinical expertise. The Trustees keep the major risks to which the charity is exposed under review and, where reasonable and practicable, procedures have been established with a view to mitigating the consequences of those risks that have been identified.

Trustee training and induction

New Trustees are provided with a formal induction programme incorporating the opportunity to meet key staff, and an induction pack of documentation including the charity’s constitution, recent Annual Reports and Accounts, recent Board minutes and the current Strategic Plan.

Structure, delegation and decision-making

The decision-making process operates as follows:

At the strategic level, the Board of Trustees regularly reviews Saving Faces’ direction in the wider context of clinical research, requiring the Chief Executive to identify relevant key issues and present options for its consideration. Due governance remains a key requirement.

The Chief Executive and Clinical Research Manager coordinate the development, implementation and running of clinical trials, audits and special projects across participating (hospital) sites in the UK. This includes project progress, feedback, managing project changes and ensuring smooth collaboration with partner sites. They are responsible for leading the team of Clinical Research staff.

The Chief Executive and Finance Manager are responsible for the financial oversight of the Charity including budgeting, financial planning and monitoring as well as financial reporting and the creation and monitoring of internal controls and accounting policies. It presents a report to the Board at each of its meetings.

At the operational level, the Board delegates the day-today running of the Charity to the Chief Executive, requiring him to deliver every aspect of governance, planning and performance in accordance with the agreed strategic direction. The Board is kept appraised of personnel, awareness, research programme and budgetary issues.

Research Programme: Peer Review

Given the importance of expert independent peer review in validating applications for new research grants and the verification of outcomes, the Scientific Advisory Board (SAB) provides the Board of

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

Trustees with the necessary degree of objectivity as to the quality, value for money and efficiency of research that the Charity currently funds or may consider funding.

Key management personnel and remuneration policy

Saving Faces is committed to attracting and retaining talented staff. Staff are kept fully informed of the organisation’s strategy and objectives, and individual performance is reviewed throughout the year. Learning and development remain a priority. Volunteer personnel are engaged for specific tasks. The key management personnel comprise the Trustees and the Chief Executive. Trustees do not receive remuneration, and the Chief Executive is unpaid and donates to the charity.

Internal control and risk management

Saving Faces has a formal risk management process through which the Chief Executive and Management Team identify the major risks to which the charity may be exposed and has ranked these by likelihood and impact, culminating in a risk control document which is updated when necessary. All significant risks, together with current mitigation actions, are reported to the Trustees as soon as possible and a risk agenda item will be added to all Trustee meetings. The Trustees are satisfied that systems have been developed and are in place to mitigate identified risks to an acceptable level.

Several other policies, deal with risk management and risk assessment e.g. Health and Safety Policy, Privacy etc. All policies are reviewed regularly and updated in line with changes in legislation, regulation and best practice. New policies are introduced as required.

The principal risks and uncertainties identified by the charity are as follows:

==> picture [452 x 17] intentionally omitted <==

----- Start of picture text -----
Risk identified Action taken to mitigate the risk
----- End of picture text -----

Risk identified
Action taken to mitigate the risk		 Risk identified
Action taken to mitigate the risk
Financial: the challenging economic
climate has resulted in low-income
generation and has affected fundraising
activities and targets. This could impact
our ability to fulfil our key charitable
objectives and commitments to research
and audit.
All income streams have been re-evaluated,
and plans are in place to diversify and
increase fundraising activities.

Fundraising progress is monitored on a monthly
basis to ensure targets are met.

The adequacy of financial returns achieved is
monitored.

Financial updates, cash flows and reserve levels
are presented to the Chief Executive regularly.

Financial updates, cash flows and reserve levels
are presented to the Board of Trustees at their
meetings.

The reserves policy is regularly reviewed as well
as the reserves level.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

Information Governance: ensuring that
personal data is stored and handled
securely in compliance with the Data
Protection Act 2018.
Implementation of policies and measures to
secure and protect data.

Yearly review of system security and
authorisation procedures, undertaking
regular access audits, and configuring
automatic password change prompts to IT
systems where possible

All staff and volunteers receive refresher
training on Information Governance policies
and procedures.

The Data Protection Officer and Information
Governance Lead ensure that the
charity is appropriately compliant.

An Information Governance report will be
provided to the Trustees at each meeting.
Personnel risk: ensuring staff welfare,
morale and workload are regularly
considered to minimise loss of key staff
and skills.
All staff have the opportunity at any point to
have a meeting with their regular line manager
to raise issues in addition to weekly staff
meetings.

All staff receive relevant training to enable
them to perform their duties.

There is a review of rates of pay, training,
working conditions and job satisfaction.

The Chief Executive has prepared a
whistleblowing facility to give staff the
opportunity to report any misconduct within
the charity.

In an event of loss of key staff, there will be
succession planning and handovers to ensure a
smooth transition.

Public benefit

The Trustees believe the charity has fully met the requirement to provide benefit to the public and have paid due regard to Charity Commission guidance -section 17 of the Charities Act 2011 and PB2 Public Benefit: Running a Charity.

Patrons

Saving Faces invites well-known, respected people to be Patrons. They do not have any decisionmaking powers but receive regular reports about the charity's work. Our current patrons are: Tony Adams MBE, Sir Alex Ferguson CBE, Julia Hobsbawm OBE, Carole Stone CBE, Lord Clive Hollick, Baroness Helena Kennedy KC, Kathy Lette, Nichola McAuliffe, Sir Jonathan Pryce CBE, Jon Snow, Ruth Rogers MBE, Hayley Sieff, John Miskelly, Nick Kalavrezos, Rima Horton, Peter Dyer OBE, Neil Shah and Professor Paul Coulthard.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

The Trustee’s report was approved by the Board of Trustees

(pat by:

……………………………………… 4DE3FAB6196E418... Patrick Magennis Trustee

28 April 2026 Date ………………………………………………….

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF SAVING FACES

I report to the Trustees on my examination of the financial statements of Saving Faces (the Charity) for the year ended 30 June 2025.

Responsibilities and basis of report

As the Trustees of the Charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011.

I report in respect of my examination of the Charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

Your attention is drawn to the fact that the charity has prepared the financial statements in accordance with the relevant version of the Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. I understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practice.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

(en vn Bilis

Corné von Wielligh ACA

MJ Bushell Audit LLP Ground Floor Kings House 101-135 Kings Road Brentwood Essex CM14 4DR

29 April 2026 Dated: .........................

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 30 JUNE 2025

Unrestricted
Unrestricted
Restricted
funds
funds
funds
2025
2024
2024
Notes
£
£
£
Income from:
Donations and legacies
3
183,478
322,224
-
Charitable activities
4
5,091
5,016
-
Investments
5
6,823
5,029
-
Total income
195,392
332,269
-
Expenditure on:
Raising funds
6
6,140
4,797
-
Charitable activities
7
174,770
153,589
4,930
Total expenditure
180,910
158,386
4,930
Net income
14,482
173,883
(4,930)
Transfers between funds
-
(4,930)
4,930
Net movement in funds
9
14,482
168,953
-
Reconciliation of funds:
Fund balances at 1 July 2024
461,120
292,167
-
Fund balances at 30 June 2025
475,602
461,120
-		 Total
2024
£
322,224
5,016
5,029
332,269
4,797
158,519
163,316
168,953
-
168,953
292,167
461,120

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

BALANCE SHEET

AS AT 30 JUNE 2025

2025 2024
Notes £ £ £ £
Fixed assets
Tangible assets 12 1,497 2,690
Current assets
Debtors 13 10,404 9,283
Cash at bank and in hand 469,777 452,014
480,181 461,297
Creditors: amounts falling due within 14
one year (6,076) (2,867)
Net current assets 474,105 458,430
Total assets less current liabilities 475,602 461,120
The funds of the Charity
Unrestricted funds 16 475,602 461,120
475,602 461,120

28 April 2026 The financial statements were approved by the Trustees on ......................... (pat .............................. 4DE3FAB6196E418... by: Patrick Magennis Trustee

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

1 Accounting policies

Charity information

Saving Faces – The Facial Surgery Research Foundation is the only charity in the UK solely dedicated to reducing the incidence of facial injuries, disorders and diseases including oral cancer worldwide.

1.1 Basis of preparation

The financial statements have been prepared in accordance with the Charity's governing document, the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The Charity is a Public Benefit Entity as defined by FRS 102.

The Charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

Endowment funds are subject to specific conditions by donors that the capital must be maintained by the Charity.

1.4 Income

Income is recognised when the Charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the Charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the Charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

1 Accounting policies

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office equipment 25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Impairment of fixed assets

At each reporting end date, the Charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9 Financial instruments

The Charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Charity's balance sheet when the Charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

1 Accounting policies

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Charity’s contractual obligations expire or are discharged or cancelled.

1.10 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the Charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the Charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from donations and legacies

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Donations and gifts 183,478 322,224

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Charitable activities
Sale of services 4,766 5,016
Other income 325 -
5,091 5,016

5 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 6,823 5,029
6 Expenditure on raising funds
Unrestricted Unrestricted
funds funds
2025 2024
£ £
Fundraising and publicity
Other fundraising costs 6,140 4,797

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

7 Expenditure on charitable activities

Charitable Charitable
activities activities
2025 2024
£ £
Direct costs
Staff costs 28,909 51,346
Research and clinical trials 4,602 41
Training and outreach 11,774 7,532
N3MA 3rd Molar Audit - 10
45,285 58,929
Share of support and governance costs (see note 8)
Support 129,485 99,590
174,770 158,519
Analysis by fund
Unrestricted funds 174,770 153,589
Restricted funds - 4,930
174,770 158,519
8 Support costs allocated to activities
2025 2024
£ £
Staff costs 56,430 51,475
Depreciation 1,193 1,164
Insurance 4,334 4,031
Telephone 110 390
Printing, postage and stationery 538 1,379
Rent and premises costs 31,462 26,571
IT costs 31,700 10,838
Independent examiners fees 2,820 3,000
Legal and professional fees 828 648
Bank charges 60 110
Travel 10 (16)
129,485 99,590
Analysed between:
Charitable activities 129,485 99,590

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

9
Net movement in funds
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements
Depreciation of owned tangible fixed assets
10
Employees
The average monthly number of employees during the year was:
Employment costs
Wages and salaries
Social security costs
Other pension costs
There were no employees whose annual remuneration was more than £60,000.
Remuneration of key management personnel
The remuneration of key management personnel is as follows: £42,899 (2024 -
£31,700)
Aggregate compensation		 2025
£
2,760
1,193
2025
Number
3
2025
£
84,020
(4,273)
5,592
85,339
2025
£
42,899		 2024
£
2,760
1,164
2024
Number
4
2024
£
93,308
1,744
7,769
102,821
2024
£
31,700

11 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

12 Tangible fixed assets

Cost
At 1 July 2024
At 30 June 2025
Depreciation and impairment
At 1 July 2024
Depreciation charged in the year
At 30 June 2025
Carrying amount
At 30 June 2025
At 30 June 2024
13
Debtors
Amounts falling due within one year:
Prepayments and accrued income
14
Creditors: amounts falling due within one year
Other taxation and social security
Trade creditors
Accruals and deferred income
15
Retirement benefit schemes
Defined contribution schemes
Charge to profit or loss in respect of defined contribution schemes		 Office
equipment
£
51,557
51,557
48,867
1,193
50,060
1,497
2,690
2025
2024
£
£
10,404
9,283
2025
2024
£
£
1,173
5
366
162
4,537
2,700
6,076
2,867
2025
2024
£
£
5,592
7,769		 Office
equipment
£
51,557
51,557
48,867
1,193
50,060
1,497
2,690
2025
2024
£
£
10,404
9,283
2025
2024
£
£
1,173
5
366
162
4,537
2,700
6,076
2,867
2025
2024
£
£
5,592
7,769
51,557
48,867
1,193
50,060
1,497
2,690
2024
£
9,283
2024
£
5
162
2,700
2,867
2024
£
7,769

The Charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Charity in an independently administered fund.

Docusign Envelope ID: 7678CF79-9D4B-4B28-AC8E-145CD37E6C18

SAVING FACES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2025

16 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 July 2024 Incoming Resources Transfers At 30 June
resources expended 2025
£ £ £ £ £
General 461,120 195,392 (180,910) - 475,602
Previous year: At 1 July 2023 Incoming Resources Transfers At 30 June
resources expended 2024
£ £ £ £ £
General 292,167 332,269 (158,386) (4,930) 461,120

17 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).